3rd UPDATE: FDA Strengthens Topamax Warning On Birth Defects Data

The U.S. Food and Drug Administration is strengthening warnings on topiramate, an antiseizure drug that is also used to prevent migraines, because new data suggest an increased risk of birth defects when used during pregnancy.

3rd UPDATE: FDA Strengthens Topamax Warning On Birth Defects Data